Guide to Minimize Microbial Food Safety Hazards for Fresh Fruits and Vegetables; Request for Comments and for Scientific Data and Information, 51306-51309 [E8-20187]
Download as PDF
51306
Federal Register / Vol. 73, No. 170 / Tuesday, September 2, 2008 / Notices
development or approval, of a drug
product, and conduct otherwise relating
to the regulation of a drug product
under the act.
As a result of the foregoing finding,
Dr. Maria Anne Kirkman Campbell is
permanently debarred from providing
services in any capacity to a person with
an approved or pending drug product
application under sections 505, 512, or
802 of the act (21 U.S.C. 355, 360b, or
382), or under section 351 of the Public
Health Service Act (42 U.S.C. 262),
effective as stated in the DATES section
of this document (see section
306(c)(1)(B) and (c)(2)(A)(ii) and 201(dd)
of the act (21 U.S.C. 321(dd))). Any
person with an approved or pending
drug product application who
knowingly uses the services of Dr.
Campbell in any capacity, during her
period of debarment, will be subject to
civil money penalties (section 307(a)(6)
of the act (21 U.S.C. 335b(a)(6))). If Dr.
Campbell, during her period of
debarment, provides services in any
capacity to a person with an approved
or pending drug product application,
she will be subject to civil money
penalties (section 307(a)(7) of the act).
In addition, FDA will not accept or
review any abbreviated new drug
application submitted by or with the
assistance of Dr. Campbell during her
period of debarment (section
306(c)(1)(B) of the act).
Any application by Dr. Campbell for
special termination of debarment under
section 306(d)(4) of the act should be
identified with Docket No. FDA–2006–
N–0166 and sent to the Division of
Dockets Management (see ADDRESSES).
All such submissions are to be filed in
four copies. The public availability of
information in these submissions is
governed by 21 CFR 10.20(j). Publicly
available submissions may be seen in
the Division of Dockets Management
between 9 a.m. and 4 p.m., Monday
through Friday.
Dated: August 22, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E8–20295 Filed 8–29–08; 8:45 am]
erowe on PROD1PC64 with NOTICES
BILLING CODE 4160–01–S
VerDate Aug<31>2005
14:40 Aug 29, 2008
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2008–N–0455]
Guide to Minimize Microbial Food
Safety Hazards for Fresh Fruits and
Vegetables; Request for Comments
and for Scientific Data and Information
AGENCY:
Food and Drug Administration,
HHS.
Notice; request for comments
and for scientific data and information.
ACTION:
SUMMARY: The Food and Drug
Administration (FDA) is requesting
comments and scientific data and
information that may assist the agency
to improve the guidance to industry set
forth in the ‘‘Guide to Minimize
Microbial Food Safety Hazards for Fresh
Fruits and Vegetables,’’ issued in 1998.
Specifically, FDA is seeking information
about current agricultural practices and
conditions used to grow, harvest, pack,
cool, and transport fresh produce; risk
factors for contamination of fresh
produce associated with these practices;
and possible measures that FDA could
implement that would enhance the
safety of fresh produce.
DATES: Submit written comments and
scientific data and information or
electronic comments by December 31,
2008.
Submit written comments
and scientific data and information to
the Division of Dockets Management
(HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. Submit
electronic comments and scientific data
and information to https://
www.regulations.gov. See the
SUPPLEMENTARY INFORMATION section for
electronic access to this document.
FOR FURTHER INFORMATION CONTACT:
Michelle A. Smith, Center for Food
Safety and Applied Nutrition (HFS–
317), Food and Drug Administration,
5100 Paint Branch Pkwy., College Park,
MD 20740–3835, 301–436–2024.
SUPPLEMENTARY INFORMATION:
ADDRESSES:
I. Background
A. Food Safety and Fresh Produce
FDA is responsible for ensuring the
safety of all domestic and imported
fresh fruits and vegetables consumed in
the United States. Fresh fruits and
vegetables are those that are likely to be
sold to consumers in an unprocessed or
minimally processed (i.e., raw) form.
Fresh fruits and vegetables may be
intact and whole, such as whole apples,
Jkt 214001
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
or cut in the act of harvest, such as
heads of lettuce and bunches of
broccoli.
Because most fresh produce is grown
in a natural environment, it is
vulnerable to contamination with
pathogens (i.e., bacteria or other
organisms that can cause disease).
Factors that may affect the occurrence of
such contamination include agricultural
and/or post-harvest water quality, the
use of manure as fertilizer, the presence
of wild or domestic animals in or near
fields or packing areas, worker health
and hygiene, environmental conditions,
production activities, and equipment
and facility sanitation. Consequently,
the manner in which fresh produce is
grown, harvested, packed, cooled, and
transported is crucial to minimizing the
risk of microbial contamination. (We
use the term ‘‘microbial contamination’’
to refer to contamination with any
microorganism.)
Data reported to the U.S. Centers for
Disease Control and Prevention (CDC)
indicate that between 1973 and 1997
reported outbreaks of foodborne illness
in the United States associated with
fresh produce increased in absolute
numbers and as a proportion of all
reported foodborne outbreaks (Ref. 1).
(By ‘‘outbreak,’’ we mean the occurrence
of two or more cases of a similar illness
resulting from the ingestion of a
common food.) Unpublished data
compiled by FDA indicate that from
1996 to 2007 there were approximately
72 reported outbreaks of foodborne
illness associated with approximately
20 fresh produce commodities. Of this
total, 13 outbreaks were associated with
tomatoes, 11 outbreaks were associated
with melons, and 24 outbreaks were
associated with leafy greens such as
lettuce and spinach (Ref. 2). These
outbreaks involved a number of
pathogens, including Escherichia coli
(E. coli) O157:H7 and Salmonella
species, and involved both domestic
and imported produce. These totals
include only those outbreaks in which
our investigation has indicated that the
contamination of the produce was not a
result of exposure to an infected food
handler or other unsafe food handling
practice at the place of preparation and
consumption (i.e., home or restaurant).
There have also been a number of
reported outbreaks associated with fresh
produce in 2008.
B. FDA’s GAPs/GMPs Guide
FDA places a high priority on
identifying and promoting measures
that can reduce the incidence of
foodborne illness associated with fresh
produce. In 1998, FDA and the U.S.
Department of Agriculture issued
E:\FR\FM\02SEN1.SGM
02SEN1
erowe on PROD1PC64 with NOTICES
Federal Register / Vol. 73, No. 170 / Tuesday, September 2, 2008 / Notices
guidance to industry entitled ‘‘Guide to
Minimize Microbial Food Safety
Hazards for Fresh Fruits and
Vegetables’’ (Ref. 3), to enhance the
safety of fresh produce, to assist the
fresh produce industry in addressing
common risk factors in their operations,
and to minimize potential food safety
hazards. (The document is referred to
hereinafter as the ‘‘GAPs/GMPs
Guide’’—GAPs is an abbreviation of
‘‘good agricultural practices’’ and GMPs
is an abbreviation of ‘‘good
manufacturing practices.’’) While FDA
recognizes current technologies cannot
eliminate all potential food safety
hazards associated with fresh produce
that will be eaten raw, the GAPs/GMPs
Guide emphasizes that implementation
of risk reduction measures is critical to
minimizing these potential food safety
hazards. The agency has worked with
the fresh produce industry and other
food safety partners since the issuance
of the GAPs/ GMPs Guide to promote its
recommendations and to advance the
scientific knowledge applicable to
enhancing the safety of fresh produce,
and the GAPs/GMPs Guide has been
used as a basis for a number of food
safety programs, both in the United
States and internationally. Choices by
buyers to purchase from producers and
other suppliers that provide self- or
third-party audit verification that they
are following the GAPs/GMPs Guide
have further promoted adoption of the
guidance.
Subsequent to the issuance of the
GAPs/GMPs Guide, FDA has
undertaken a number of produce safety
initiatives that have enhanced its
understanding of the effectiveness of the
GAPs/GMPs Guide in reducing the risk
of produce-associated foodborne illness.
Examples include the 2004 ‘‘Produce
Safety From Production to
Consumption: 2004 Action Plan to
Minimize Foodborne Illness Associated
with Fresh Produce Consumption,’’
commonly called the ‘‘Produce Safety
Action Plan’’ (Ref. 4), which focuses on
prevention of contamination,
minimization of public health impacts
when contamination does occur,
communication with the public and
stakeholders, and facilitation and
support of research; the multi-year
‘‘Leafy Greens Safety Initiative’’ (Ref. 5),
launched in 2006 in collaboration with
the State of California, which involves
assessment of practices and conditions
at select farms and facilities in
California, including adoption and
implementation of good agricultural
practice and good manufacturing
practice recommendations (for packing
houses) and requirements (for fresh-cut
VerDate Aug<31>2005
14:40 Aug 29, 2008
Jkt 214001
processing facilities); and the 2007
‘‘Tomato Safety Initiative’’ (Ref. 6), a
multi-year collaboration similar to the
‘‘Leafy Greens Safety Initiative’’ with
the States of Virginia and Florida, as
well as several universities and
members of the produce industry.
Available data and FDA’s experience
suggest that the GAPs/GMPs Guide (and
other public and private sector efforts)
have accurately identified certain
potential sources of microbial
contamination of fresh produce, such as
agricultural water and worker health
and hygiene. Data and experience also
indicate that the recommendations in
the GAPs/GMPs Guide can be effective
when implemented. However, the fact
that outbreaks of foodborne illness
associated with fresh produce continue
to occur supports a close examination of
the extent to which the
recommendations in the GAPs/GMPs
Guide have been implemented; the
extent to which they have been
effective, if implemented properly; and
what additional or different
interventions might be appropriate to
reduce the risk of future outbreaks. The
agency recognized when it issued the
GAPs/GMPs Guide in 1998 that it would
need to be updated ‘‘[a]s new
information and technological advances
expand the understanding of those
factors associated with identifying and
reducing microbial food safety hazards’’
(Ref. 3). In the 10 years since the GAPs/
GMPs Guide was released many changes
have occurred in the produce industry,
and a great deal of new knowledge and
information have become available. In
addition, the agency now has 10 years
experience in implementing this
guidance and observing how and the
extent to which it has been
implemented by the industry.
In addition to the initiatives described
previously, in 2007 FDA held two
public hearings to inform stakeholders
about produce-associated outbreaks and
to solicit comments to inform the
agency in determining the next steps
(Ref. 7). In both instances, the agency
asked a series of questions. Among these
questions, we asked whether FDA’s
current GAPs/GMPs Guide needs to be
expanded or otherwise revised, and if
the response was yes, we solicited
comments about what areas need to be
expanded or otherwise revised.
Comments were generally in agreement
that the basic principles set out in the
1998 guidance remain sound. However,
they were split on whether FDA should
update the GAPs/GMPs Guide and, if so,
how it might be revised. Several
comments suggested the GAPs/GMPs
Guide should provide more specific and
directive recommendations. A number
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
51307
of comments suggested that the GAPs/
GMPs Guide needs more explicit
information to facilitate risk assessment.
Other comments urged FDA to keep the
GAPs/GMPs Guide broad in scope, and
to focus instead on education/outreach
to promote adoption of existing
recommendations.
FDA has taken the comments received
in response to the 2007 public hearings
into consideration and incorporated
relevant suggestions as it conducts the
produce safety activities mentioned in
this Federal Register document and
other activities implementing the
‘‘Produce Safety Action Plan.’’ However,
because most comments did not provide
substantive information or data in
response to this question, FDA has
determined that it would benefit from
another, more focused opportunity for
public comment.
Thus, FDA is now soliciting
comments and scientific data and
information on any possible measures
and technological advances that would
assist the agency in improving the
agency’s current GAPs/GMPs Guide.
Specifically, FDA is seeking information
and comment on the issues and
questions in section II of this document.
When possible, please provide scientific
information and data in support of your
comments. In addition, please provide
information as specific as is feasible
about the estimated costs and benefits
associated with your responses (e.g., the
costs and benefits of current practices
and/or the cost and benefits of any
recommendations you may make). FDA
is not seeking information and comment
on issues of traceability in this
document, because FDA plans to do so
in the context of a public meeting.
II. Issues and Questions
Issue 1: The GAPs/GMPs Guide
addresses potential sources of microbial
contamination associated with a range
of issues, or variables, such as: Water
(both agricultural water and post harvest
water uses); manure and municipal biosolids; worker health and hygiene;
packing facility sanitation;
transportation; and traceback (Ref. 3).
Data from our experience over the past
decade support the inclusion of many of
these issues as risk factors for produceassociated foodborne illness outbreaks.
Some of these potential sources of
contamination in particular, such as
worker health and hygiene, water
quality (pre- and post-harvest), domestic
and wild animal issues, and facility and
equipment sanitation have been cited
frequently by investigators during
inspections at farms and facilities that
were implicated in outbreak
investigations. On the other hand,
E:\FR\FM\02SEN1.SGM
02SEN1
erowe on PROD1PC64 with NOTICES
51308
Federal Register / Vol. 73, No. 170 / Tuesday, September 2, 2008 / Notices
although there remains a significant
potential for contamination, some issue
areas, such as the intentional use of
manure or bio-solids as an agricultural
input, have not been cited as a potential
source of contamination to the same
extent. The current guidance does not
attempt to rank the potential hazard
variables in terms of relative risk or
importance.
Question 1. Should any future GAPs/
GMPs Guide rank or prioritize among
potential issues according to relative
risk or importance? If yes, please offer
suggestions of how that information
could most effectively be presented in a
way that does not detract from the broad
scope of the current guidance.
Issue 2: The GAPs/GMPs Guide tends
to be arranged by issue area, while more
recent industry commodity specific
supply chain guidelines are divided
according to where the commodity is
within the supply chain (e.g.,
production, packing, distribution) and/
or the chronological order of activities at
each step.
Question 2. How should the GAPs/
GMPs Guide be organized to enhance its
usefulness?
Question 3. While the GAPs/GMPs
Guide has been generally accepted and
widely adopted, we know that there are
entities in the fresh produce industry
that are not aware of it. What measures
can be taken, and by whom, to expand
awareness by the fresh produce industry
of the GAPs/GMPs Guide?
Question 4. How should the GAPs/
GMPs Guide be modified to motivate all
operations to implement? Please include
information on economic impact.
Question 5. Can the GAPs/GMPs
Guide be applied equally to, and
implemented by, domestic and foreign
growers and packers? If not, should the
GAPs/GMPs Guide be revised to
incorporate additional options or
special considerations (e.g., utilizing
draft animals for agricultural tasks) for
application and implementation? Please
explain.
Question 6. Is there a need for
additional guidance to assist an operator
in determining which provisions of the
Current Good Manufacturing Practice
regulations in part 110 (21 CFR part
110) (e.g., post-harvest water quality,
disease control, cleanliness, and
supervision) could be implemented
voluntarily for operations that currently
are excluded under § 110.19? If so,
which ones?
Issue 3: Written food safety plans,
sanitation standard operating
procedures (SSOPs), standard operating
procedures (SOPs), and monitoring
records serve as useful tools for both
industry and regulators. Such records
VerDate Aug<31>2005
14:40 Aug 29, 2008
Jkt 214001
assist operators to conduct operations in
a manner that enhances the safety of
fresh produce. For growers, an
assessment of factors such as the field
environment and agricultural inputs
contributes to the development of
written food safety plans and SOPs, and
also helps to determine which factors
should be monitored and the frequency
of such monitoring. (The use of the term
‘‘assessment’’ refers to an evaluation
conducted by, or on behalf of, a grower
or operator to identify measures to
enhance food safety.)
Written food safety plans, SOPs,
SSOPs, and monitoring records also
assist regulators to verify consistent and
long-term implementation of certain
practices. On-site inspections, either
alone or in conjunction with records
review, are another approach to such
verification. (The use of the term
‘‘inspection’’ refers to an evaluation
conducted by, or on behalf of, a
regulator to evaluate whether operations
comply with applicable guidance or
regulations. The term ‘‘audit’’ refers to
a self or third-party evaluation of
whether operations are consistent with
voluntary guidelines and written food
safety plans or SSOPs developed by the
grower, operator, or buyer.)
Question 7. Should the GAPs/GMPs
Guide recommend that growers and/or
other relevant operations develop a
written food safety plan, written SOPs,
and/or written SSOPs? If so, please
describe the types of information or
recommendations that you believe
would be helpful.
Question 8. Records can be divided
into the following two broad groups: (1)
Records to facilitate traceback, and (2)
non-traceback or operational records.
Does the GAPs/GMPs Guide provide
sufficient recommendations regarding
record keeping? If not, please describe
what would be most helpful and why,
e.g., information about the record
keeping regulation (21 CFR 1 subpart J),
guidance on what makes a ‘‘good’’
record, guidance on periodic record
review and verification, and required or
recommended record retention times.
What types of monitoring records or
other documentation would be most
useful to industry and regulators?
Question 9. The recent produce safety
initiatives concerning leafy greens and
tomatoes (Refs. 5 and 6) have
highlighted the importance of
performing environmental assessments
(e.g., assessing water source quality,
water distribution systems, animal
presence, and other risk factors that may
be associated with the production
environment) before planting,
throughout production, and prior to
harvest. Would it be useful to enhance
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
coverage of these concepts in the GAPs/
GMPs Guide? If yes, please describe.
Question 10. Several newer produce
safety programs, such as the California
Leafy Green Products Handler
Marketing Agreement (Ref. 8),
incorporate recommendations (or
requirements) for microbial testing.
Does the information on microbial
testing in the GAPs/GMPs Guide
provide sufficient information to assist
operators in designing a meaningful and
cost effective testing program? If not,
please describe what types of additional
information would be most useful, such
as how and where microbial testing
might best be used to achieve food
safety objectives, e.g., building a history
of agricultural water quality, making
best management decisions, verifying
food safety operations.
Question 11. Some comments
submitted in connection with the 2007
public hearings expressed concerns that
field management activities intended to
minimize microbial hazards, such as
removing vegetation to reduce animal
harborage near the production field,
could have a negative, albeit
unintended, impact on the environment
and water sheds, among other areas.
What data support these concerns?
Could/should the GAPs/GMPs Guide do
more to identify, address, and possibly
mitigate unintended environmental
consequences of food safety measures?
Question 12. Are there existing
regulatory requirements at the Federal,
State, or local level that act as a
disincentive (or as an incentive) for
growers or other operators to implement
agricultural or manufacturing practices
that should be taken into consideration
when updating this guidance to reduce
the risk of microbial contamination of
fresh produce? If yes, please identify
and explain.
III. Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) written or electronic
comments regarding this document.
Submit a single copy of electronic
comments or two paper copies of any
mailed comments, except that
individuals may submit one paper copy.
Comments are to be identified with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
Please note that on January 15, 2008,
the FDA Division of Dockets
Management Web site transitioned to
the Federal Dockets Management
System (FDMS). FDMS is a
Government-wide, electronic docket
E:\FR\FM\02SEN1.SGM
02SEN1
Federal Register / Vol. 73, No. 170 / Tuesday, September 2, 2008 / Notices
management system. Electronic
comments or submissions will be
accepted by FDA only through FDMS at
https://www.regulations.gov.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
IV. References
[Docket No. FDA–2008–N–0466]
The following references have been
placed on display in the Division of
Dockets Management (see ADDRESSES)
and may be seen by interested persons
between 9 a.m. and 4 p.m., Monday
through Friday. (FDA has verified the
Web site addresses, but FDA is not
responsible for any subsequent changes
to the Web sites after this document
publishes in the Federal Register.)
Over the Counter Cough and Cold
Medication for Pediatric Use; Notice of
Public Hearing; Correction
1. Sivapalasingam, S., et al. ‘‘Fresh
Produce: A Growing Cause of Outbreaks of
Foodborne Illness in the United States, 1973
through 1997,’’ Journal of Food Protection
67(10): 2342–53, 2004.
2. U.S. Food and Drug Administration,
1996 to 2007 Produce Outbreaks
(unpublished compilation).
3. U.S. Food and Drug Administration,
‘‘Guide to Minimize Microbial Food Safety
Hazards for Fresh Fruits and Vegetables,’’
October 26, 1998, available at https://
www.cfsan.fda.gov/~dms/prodguid.html.
4. U.S. Food and Drug Administration,
‘‘Produce Safety From Production to
Consumption: 2004 Action Plan to Minimize
Foodborne Illness Associated with Fresh
Produce Consumption,’’ October 2004,
available at https://www.cfsan.fda.gov/~dms/
prodpla2.html.
5. U.S. Food and Drug Administration,
‘‘Leafy Greens Safety Initiative—2nd year,’’
October 4, 2007, available at https://
www.cfsan.fda.gov/~dms/lettsaf2.html.
6. U.S. Food and Drug Administration,
‘‘Tomato Safety Initiative,’’ June 12, 2007,
available at https://www.cfsan.fda.gov/~dms/
tomsafe.html.
7. ‘‘Safety of Fresh Produce; Public
Hearings; Request for Comments’’ (72 FR
8750, February 27, 2007), Public hearings
held on March 20, 2007, and April 13, 2007,
https://www.regulations.gov/fdmspublic/
component/
main?main=DocketDetail&d=FDA–2007–N–
0380.
8. California Leafy Green Products Handler
Marketing Agreement, available at https://
www.caleafygreens.ca.gov.
II. Electronic Access
erowe on PROD1PC64 with NOTICES
Persons with access to the Internet
may obtain the document at https://
www.cfsan.fda.gov/~dms/
prodguid.html.
Dated: August 19, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E8–20187 Filed 8–29–08; 8:45 am]
BILLING CODE 4160–01–S
VerDate Aug<31>2005
14:40 Aug 29, 2008
Jkt 214001
Food and Drug Administration
AGENCY:
Food and Drug Administration,
HHS.
Notice of public hearing; request
for comments; correction.
ACTION:
SUMMARY: The Food and Drug
Administration is correcting a notice
that published in the Federal Register
on August 25, 2008 (73 FR 50033). The
notice announced a public hearing to
obtain input regarding over-the-counter
(OTC) cough and cold drugs marketed
for pediatric use. Due to some confusion
regarding electronic registration, this
notice revises the electronic registration
procedures, and corrects the address for
the contact person.
DATES: The correction is effective
September 2, 2008.
FOR FURTHER INFORMATION CONTACT:
Faith Dugan, Food and Drug
Administration, 10903 New Hampshire
Ave., rm. 6182, Silver Spring, MD
20993, 301–796–3446,
Faith.Dugan@fda.hhs.gov.
In FR Doc.
E8–19657, published on August 25,
2008 (73 FR 50033), the following
correction is made to ADDRESSES:
1. On page 50033, in the first and
second columns, the ADDRESSES section
is corrected to read as follows:
ADDRESSES: Submit written comments to
the Division of Dockets Management
(HFA–305), Food and Drug
Administration, 5630 Fishers Lane,
rm. 1061, Rockville, MD 20852.
E-mail electronic registration to:
Faith.Dugan@fda.hhs.gov. Anyone who
has already registered via https://
www.regulations.gov does not have to
re-register. The agency will accept those
registrations.
Submit electronic comments to https://
www.regulations.gov. All comments
should be identified with the docket
number found in brackets in the
heading of this document.
Transcripts of the hearing will be
available for review at the Division of
Dockets Management and on the
Internet at https://www.regulations.gov
approximately 30 days after the hearing.
For Registration to Attend and/or
Participate in the Hearing: Seating at the
hearing is limited. People interested in
attending should submit electronic
registration to Faith Dugan by close of
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
51309
business on September 15, 2008.
Registration is free and will be on a firstcome, first-served basis. Written or
electronic comments will be accepted
until December 2, 2008.
If you wish to make an oral
presentation at the hearing, you must
state your intention on your registration
submission (see ADDRESSES). To speak,
submit your name, title, business
affiliation, address, telephone and fax
numbers, and e-mail address. FDA has
included questions for comment in
section II of this document. You should
also identify by number each question
you wish to address in your
presentation. FDA will do its best to
accommodate requests to speak.
Individuals and organizations with
common interests are urged to
consolidate or coordinate their
presentations, and to request time for a
joint presentation. FDA will determine
the amount of time allotted to each
presenter and the approximate time that
each oral presentation is scheduled to
begin.
If you need special accommodations
because of a disability, please inform
Faith Dugan, (see For Information on the
Hearing Contact).
For Information on the Hearing
Contact: Faith Dugan, Food and Drug
Administration, 10903 New Hampshire
Ave., rm. 6182, Silver Spring, MD 20993
, 301–796–3446, FAX: 301–847–4752, email: Faith.Dugan@fda.hhs.gov.
Dated: August 27, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E8–20370 Filed 8–28–08; 11:15 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
E:\FR\FM\02SEN1.SGM
02SEN1
Agencies
[Federal Register Volume 73, Number 170 (Tuesday, September 2, 2008)]
[Notices]
[Pages 51306-51309]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-20187]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2008-N-0455]
Guide to Minimize Microbial Food Safety Hazards for Fresh Fruits
and Vegetables; Request for Comments and for Scientific Data and
Information
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; request for comments and for scientific data and
information.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is requesting comments
and scientific data and information that may assist the agency to
improve the guidance to industry set forth in the ``Guide to Minimize
Microbial Food Safety Hazards for Fresh Fruits and Vegetables,'' issued
in 1998. Specifically, FDA is seeking information about current
agricultural practices and conditions used to grow, harvest, pack,
cool, and transport fresh produce; risk factors for contamination of
fresh produce associated with these practices; and possible measures
that FDA could implement that would enhance the safety of fresh
produce.
DATES: Submit written comments and scientific data and information or
electronic comments by December 31, 2008.
ADDRESSES: Submit written comments and scientific data and information
to the Division of Dockets Management (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852.
Submit electronic comments and scientific data and information to
https://www.regulations.gov. See the SUPPLEMENTARY INFORMATION section
for electronic access to this document.
FOR FURTHER INFORMATION CONTACT: Michelle A. Smith, Center for Food
Safety and Applied Nutrition (HFS-317), Food and Drug Administration,
5100 Paint Branch Pkwy., College Park, MD 20740-3835, 301-436-2024.
SUPPLEMENTARY INFORMATION:
I. Background
A. Food Safety and Fresh Produce
FDA is responsible for ensuring the safety of all domestic and
imported fresh fruits and vegetables consumed in the United States.
Fresh fruits and vegetables are those that are likely to be sold to
consumers in an unprocessed or minimally processed (i.e., raw) form.
Fresh fruits and vegetables may be intact and whole, such as whole
apples, or cut in the act of harvest, such as heads of lettuce and
bunches of broccoli.
Because most fresh produce is grown in a natural environment, it is
vulnerable to contamination with pathogens (i.e., bacteria or other
organisms that can cause disease). Factors that may affect the
occurrence of such contamination include agricultural and/or post-
harvest water quality, the use of manure as fertilizer, the presence of
wild or domestic animals in or near fields or packing areas, worker
health and hygiene, environmental conditions, production activities,
and equipment and facility sanitation. Consequently, the manner in
which fresh produce is grown, harvested, packed, cooled, and
transported is crucial to minimizing the risk of microbial
contamination. (We use the term ``microbial contamination'' to refer to
contamination with any microorganism.)
Data reported to the U.S. Centers for Disease Control and
Prevention (CDC) indicate that between 1973 and 1997 reported outbreaks
of foodborne illness in the United States associated with fresh produce
increased in absolute numbers and as a proportion of all reported
foodborne outbreaks (Ref. 1). (By ``outbreak,'' we mean the occurrence
of two or more cases of a similar illness resulting from the ingestion
of a common food.) Unpublished data compiled by FDA indicate that from
1996 to 2007 there were approximately 72 reported outbreaks of
foodborne illness associated with approximately 20 fresh produce
commodities. Of this total, 13 outbreaks were associated with tomatoes,
11 outbreaks were associated with melons, and 24 outbreaks were
associated with leafy greens such as lettuce and spinach (Ref. 2).
These outbreaks involved a number of pathogens, including Escherichia
coli (E. coli) O157:H7 and Salmonella species, and involved both
domestic and imported produce. These totals include only those
outbreaks in which our investigation has indicated that the
contamination of the produce was not a result of exposure to an
infected food handler or other unsafe food handling practice at the
place of preparation and consumption (i.e., home or restaurant). There
have also been a number of reported outbreaks associated with fresh
produce in 2008.
B. FDA's GAPs/GMPs Guide
FDA places a high priority on identifying and promoting measures
that can reduce the incidence of foodborne illness associated with
fresh produce. In 1998, FDA and the U.S. Department of Agriculture
issued
[[Page 51307]]
guidance to industry entitled ``Guide to Minimize Microbial Food Safety
Hazards for Fresh Fruits and Vegetables'' (Ref. 3), to enhance the
safety of fresh produce, to assist the fresh produce industry in
addressing common risk factors in their operations, and to minimize
potential food safety hazards. (The document is referred to hereinafter
as the ``GAPs/GMPs Guide''--GAPs is an abbreviation of ``good
agricultural practices'' and GMPs is an abbreviation of ``good
manufacturing practices.'') While FDA recognizes current technologies
cannot eliminate all potential food safety hazards associated with
fresh produce that will be eaten raw, the GAPs/GMPs Guide emphasizes
that implementation of risk reduction measures is critical to
minimizing these potential food safety hazards. The agency has worked
with the fresh produce industry and other food safety partners since
the issuance of the GAPs/ GMPs Guide to promote its recommendations and
to advance the scientific knowledge applicable to enhancing the safety
of fresh produce, and the GAPs/GMPs Guide has been used as a basis for
a number of food safety programs, both in the United States and
internationally. Choices by buyers to purchase from producers and other
suppliers that provide self- or third-party audit verification that
they are following the GAPs/GMPs Guide have further promoted adoption
of the guidance.
Subsequent to the issuance of the GAPs/GMPs Guide, FDA has
undertaken a number of produce safety initiatives that have enhanced
its understanding of the effectiveness of the GAPs/GMPs Guide in
reducing the risk of produce-associated foodborne illness. Examples
include the 2004 ``Produce Safety From Production to Consumption: 2004
Action Plan to Minimize Foodborne Illness Associated with Fresh Produce
Consumption,'' commonly called the ``Produce Safety Action Plan'' (Ref.
4), which focuses on prevention of contamination, minimization of
public health impacts when contamination does occur, communication with
the public and stakeholders, and facilitation and support of research;
the multi-year ``Leafy Greens Safety Initiative'' (Ref. 5), launched in
2006 in collaboration with the State of California, which involves
assessment of practices and conditions at select farms and facilities
in California, including adoption and implementation of good
agricultural practice and good manufacturing practice recommendations
(for packing houses) and requirements (for fresh-cut processing
facilities); and the 2007 ``Tomato Safety Initiative'' (Ref. 6), a
multi-year collaboration similar to the ``Leafy Greens Safety
Initiative'' with the States of Virginia and Florida, as well as
several universities and members of the produce industry.
Available data and FDA's experience suggest that the GAPs/GMPs
Guide (and other public and private sector efforts) have accurately
identified certain potential sources of microbial contamination of
fresh produce, such as agricultural water and worker health and
hygiene. Data and experience also indicate that the recommendations in
the GAPs/GMPs Guide can be effective when implemented. However, the
fact that outbreaks of foodborne illness associated with fresh produce
continue to occur supports a close examination of the extent to which
the recommendations in the GAPs/GMPs Guide have been implemented; the
extent to which they have been effective, if implemented properly; and
what additional or different interventions might be appropriate to
reduce the risk of future outbreaks. The agency recognized when it
issued the GAPs/GMPs Guide in 1998 that it would need to be updated
``[a]s new information and technological advances expand the
understanding of those factors associated with identifying and reducing
microbial food safety hazards'' (Ref. 3). In the 10 years since the
GAPs/GMPs Guide was released many changes have occurred in the produce
industry, and a great deal of new knowledge and information have become
available. In addition, the agency now has 10 years experience in
implementing this guidance and observing how and the extent to which it
has been implemented by the industry.
In addition to the initiatives described previously, in 2007 FDA
held two public hearings to inform stakeholders about produce-
associated outbreaks and to solicit comments to inform the agency in
determining the next steps (Ref. 7). In both instances, the agency
asked a series of questions. Among these questions, we asked whether
FDA's current GAPs/GMPs Guide needs to be expanded or otherwise
revised, and if the response was yes, we solicited comments about what
areas need to be expanded or otherwise revised. Comments were generally
in agreement that the basic principles set out in the 1998 guidance
remain sound. However, they were split on whether FDA should update the
GAPs/GMPs Guide and, if so, how it might be revised. Several comments
suggested the GAPs/GMPs Guide should provide more specific and
directive recommendations. A number of comments suggested that the
GAPs/GMPs Guide needs more explicit information to facilitate risk
assessment. Other comments urged FDA to keep the GAPs/GMPs Guide broad
in scope, and to focus instead on education/outreach to promote
adoption of existing recommendations.
FDA has taken the comments received in response to the 2007 public
hearings into consideration and incorporated relevant suggestions as it
conducts the produce safety activities mentioned in this Federal
Register document and other activities implementing the ``Produce
Safety Action Plan.'' However, because most comments did not provide
substantive information or data in response to this question, FDA has
determined that it would benefit from another, more focused opportunity
for public comment.
Thus, FDA is now soliciting comments and scientific data and
information on any possible measures and technological advances that
would assist the agency in improving the agency's current GAPs/GMPs
Guide. Specifically, FDA is seeking information and comment on the
issues and questions in section II of this document. When possible,
please provide scientific information and data in support of your
comments. In addition, please provide information as specific as is
feasible about the estimated costs and benefits associated with your
responses (e.g., the costs and benefits of current practices and/or the
cost and benefits of any recommendations you may make). FDA is not
seeking information and comment on issues of traceability in this
document, because FDA plans to do so in the context of a public
meeting.
II. Issues and Questions
Issue 1: The GAPs/GMPs Guide addresses potential sources of
microbial contamination associated with a range of issues, or
variables, such as: Water (both agricultural water and post harvest
water uses); manure and municipal bio-solids; worker health and
hygiene; packing facility sanitation; transportation; and traceback
(Ref. 3). Data from our experience over the past decade support the
inclusion of many of these issues as risk factors for produce-
associated foodborne illness outbreaks. Some of these potential sources
of contamination in particular, such as worker health and hygiene,
water quality (pre- and post-harvest), domestic and wild animal issues,
and facility and equipment sanitation have been cited frequently by
investigators during inspections at farms and facilities that were
implicated in outbreak investigations. On the other hand,
[[Page 51308]]
although there remains a significant potential for contamination, some
issue areas, such as the intentional use of manure or bio-solids as an
agricultural input, have not been cited as a potential source of
contamination to the same extent. The current guidance does not attempt
to rank the potential hazard variables in terms of relative risk or
importance.
Question 1. Should any future GAPs/GMPs Guide rank or prioritize
among potential issues according to relative risk or importance? If
yes, please offer suggestions of how that information could most
effectively be presented in a way that does not detract from the broad
scope of the current guidance.
Issue 2: The GAPs/GMPs Guide tends to be arranged by issue area,
while more recent industry commodity specific supply chain guidelines
are divided according to where the commodity is within the supply chain
(e.g., production, packing, distribution) and/or the chronological
order of activities at each step.
Question 2. How should the GAPs/GMPs Guide be organized to enhance
its usefulness?
Question 3. While the GAPs/GMPs Guide has been generally accepted
and widely adopted, we know that there are entities in the fresh
produce industry that are not aware of it. What measures can be taken,
and by whom, to expand awareness by the fresh produce industry of the
GAPs/GMPs Guide?
Question 4. How should the GAPs/GMPs Guide be modified to motivate
all operations to implement? Please include information on economic
impact.
Question 5. Can the GAPs/GMPs Guide be applied equally to, and
implemented by, domestic and foreign growers and packers? If not,
should the GAPs/GMPs Guide be revised to incorporate additional options
or special considerations (e.g., utilizing draft animals for
agricultural tasks) for application and implementation? Please explain.
Question 6. Is there a need for additional guidance to assist an
operator in determining which provisions of the Current Good
Manufacturing Practice regulations in part 110 (21 CFR part 110) (e.g.,
post-harvest water quality, disease control, cleanliness, and
supervision) could be implemented voluntarily for operations that
currently are excluded under Sec. 110.19? If so, which ones?
Issue 3: Written food safety plans, sanitation standard operating
procedures (SSOPs), standard operating procedures (SOPs), and
monitoring records serve as useful tools for both industry and
regulators. Such records assist operators to conduct operations in a
manner that enhances the safety of fresh produce. For growers, an
assessment of factors such as the field environment and agricultural
inputs contributes to the development of written food safety plans and
SOPs, and also helps to determine which factors should be monitored and
the frequency of such monitoring. (The use of the term ``assessment''
refers to an evaluation conducted by, or on behalf of, a grower or
operator to identify measures to enhance food safety.)
Written food safety plans, SOPs, SSOPs, and monitoring records also
assist regulators to verify consistent and long-term implementation of
certain practices. On-site inspections, either alone or in conjunction
with records review, are another approach to such verification. (The
use of the term ``inspection'' refers to an evaluation conducted by, or
on behalf of, a regulator to evaluate whether operations comply with
applicable guidance or regulations. The term ``audit'' refers to a self
or third-party evaluation of whether operations are consistent with
voluntary guidelines and written food safety plans or SSOPs developed
by the grower, operator, or buyer.)
Question 7. Should the GAPs/GMPs Guide recommend that growers and/
or other relevant operations develop a written food safety plan,
written SOPs, and/or written SSOPs? If so, please describe the types of
information or recommendations that you believe would be helpful.
Question 8. Records can be divided into the following two broad
groups: (1) Records to facilitate traceback, and (2) non-traceback or
operational records. Does the GAPs/GMPs Guide provide sufficient
recommendations regarding record keeping? If not, please describe what
would be most helpful and why, e.g., information about the record
keeping regulation (21 CFR 1 subpart J), guidance on what makes a
``good'' record, guidance on periodic record review and verification,
and required or recommended record retention times. What types of
monitoring records or other documentation would be most useful to
industry and regulators?
Question 9. The recent produce safety initiatives concerning leafy
greens and tomatoes (Refs. 5 and 6) have highlighted the importance of
performing environmental assessments (e.g., assessing water source
quality, water distribution systems, animal presence, and other risk
factors that may be associated with the production environment) before
planting, throughout production, and prior to harvest. Would it be
useful to enhance coverage of these concepts in the GAPs/GMPs Guide? If
yes, please describe.
Question 10. Several newer produce safety programs, such as the
California Leafy Green Products Handler Marketing Agreement (Ref. 8),
incorporate recommendations (or requirements) for microbial testing.
Does the information on microbial testing in the GAPs/GMPs Guide
provide sufficient information to assist operators in designing a
meaningful and cost effective testing program? If not, please describe
what types of additional information would be most useful, such as how
and where microbial testing might best be used to achieve food safety
objectives, e.g., building a history of agricultural water quality,
making best management decisions, verifying food safety operations.
Question 11. Some comments submitted in connection with the 2007
public hearings expressed concerns that field management activities
intended to minimize microbial hazards, such as removing vegetation to
reduce animal harborage near the production field, could have a
negative, albeit unintended, impact on the environment and water sheds,
among other areas. What data support these concerns? Could/should the
GAPs/GMPs Guide do more to identify, address, and possibly mitigate
unintended environmental consequences of food safety measures?
Question 12. Are there existing regulatory requirements at the
Federal, State, or local level that act as a disincentive (or as an
incentive) for growers or other operators to implement agricultural or
manufacturing practices that should be taken into consideration when
updating this guidance to reduce the risk of microbial contamination of
fresh produce? If yes, please identify and explain.
III. Comments
Interested persons may submit to the Division of Dockets Management
(see ADDRESSES) written or electronic comments regarding this document.
Submit a single copy of electronic comments or two paper copies of any
mailed comments, except that individuals may submit one paper copy.
Comments are to be identified with the docket number found in brackets
in the heading of this document. Received comments may be seen in the
Division of Dockets Management between 9 a.m. and 4 p.m., Monday
through Friday.
Please note that on January 15, 2008, the FDA Division of Dockets
Management Web site transitioned to the Federal Dockets Management
System (FDMS). FDMS is a Government-wide, electronic docket
[[Page 51309]]
management system. Electronic comments or submissions will be accepted
by FDA only through FDMS at https://www.regulations.gov.
IV. References
The following references have been placed on display in the
Division of Dockets Management (see ADDRESSES) and may be seen by
interested persons between 9 a.m. and 4 p.m., Monday through Friday.
(FDA has verified the Web site addresses, but FDA is not responsible
for any subsequent changes to the Web sites after this document
publishes in the Federal Register.)
1. Sivapalasingam, S., et al. ``Fresh Produce: A Growing Cause
of Outbreaks of Foodborne Illness in the United States, 1973 through
1997,'' Journal of Food Protection 67(10): 2342-53, 2004.
2. U.S. Food and Drug Administration, 1996 to 2007 Produce
Outbreaks (unpublished compilation).
3. U.S. Food and Drug Administration, ``Guide to Minimize
Microbial Food Safety Hazards for Fresh Fruits and Vegetables,''
October 26, 1998, available at https://www.cfsan.fda.gov/~dms/
prodguid.html.
4. U.S. Food and Drug Administration, ``Produce Safety From
Production to Consumption: 2004 Action Plan to Minimize Foodborne
Illness Associated with Fresh Produce Consumption,'' October 2004,
available at https://www.cfsan.fda.gov/~dms/prodpla2.html.
5. U.S. Food and Drug Administration, ``Leafy Greens Safety
Initiative--2nd year,'' October 4, 2007, available at https://
www.cfsan.fda.gov/~dms/lettsaf2.html.
6. U.S. Food and Drug Administration, ``Tomato Safety
Initiative,'' June 12, 2007, available at https://www.cfsan.fda.gov/
~dms/tomsafe.html.
7. ``Safety of Fresh Produce; Public Hearings; Request for
Comments'' (72 FR 8750, February 27, 2007), Public hearings held on
March 20, 2007, and April 13, 2007, https://www.regulations.gov/
fdmspublic/component/main?main=DocketDetail&d=FDA-2007-N-0380.
8. California Leafy Green Products Handler Marketing Agreement,
available at https://www.caleafygreens.ca.gov.
II. Electronic Access
Persons with access to the Internet may obtain the document at
https://www.cfsan.fda.gov/~dms/prodguid.html.
Dated: August 19, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
[FR Doc. E8-20187 Filed 8-29-08; 8:45 am]
BILLING CODE 4160-01-S